Literature DB >> 13584707

Specificity and comparative activity of the carbonic anhydrase inhibitors neptazane and diamox on animal and human eyes.

M E LANGHAM.   

Abstract

Entities:  

Keywords:  ACETAZOLAMIDE/related compounds; INTRAOCULAR PRESSURE/effect of drugs on

Mesh:

Substances:

Year:  1958        PMID: 13584707      PMCID: PMC509710          DOI: 10.1136/bjo.42.10.577

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  6 in total

1.  Combined action of diamox and potassium bicarbonate in the treatment of of chronic glaucoma.

Authors:  D A CAMPBELL; M JONES; N E RENNER; E L TONKS
Journal:  Br J Ophthalmol       Date:  1957-12       Impact factor: 4.638

2.  Aqueous humor and control of intra-ocular pressure.

Authors:  M E LANGHAM
Journal:  Physiol Rev       Date:  1958-04       Impact factor: 37.312

3.  Carbonic anhydrase inhibition. V. N5-substituted 2-acetylamino-1,3,4-thiadiazole-5-sulfonamides: metabolic conversion and use as control substances.

Authors:  T H MAREN
Journal:  J Pharmacol Exp Ther       Date:  1956-08       Impact factor: 4.030

4.  Correlation of the systemic and intraocular effects of diamox.

Authors:  D A CAMPBELL; E L TONKS; M JONES
Journal:  Br J Ophthalmol       Date:  1956-05       Impact factor: 4.638

5.  Diamox (acetazoleamide) in treatment of glaucoma.

Authors:  W M GRANT; R R TROTTER
Journal:  AMA Arch Ophthalmol       Date:  1954-06

6.  Inhibition of carbonic anhydrase by sulphonamides.

Authors:  H A Krebs
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

  6 in total
  2 in total

1.  Effect of neptazane on intra-ocular pressure in relation to its systemic action and its clinical application.

Authors:  D A CAMPBELL
Journal:  Br J Ophthalmol       Date:  1960-07       Impact factor: 4.638

2.  Succinylcholine and acetazolamide (diamox) in anaesthesia for ocular surgery.

Authors:  A S Carballo
Journal:  Can Anaesth Soc J       Date:  1965-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.